British Heart Foundation

• NCT04319627

  Collaborator, Phase 3, Recruiting, 2,700 people, 24 Mar 2020

• NCT04181749

  Collaborator, Phase 2, Status unknown, 200 people, 29 Nov 2019

• NCT03226457

  Collaborator, Phase 4, Completed, 23 people, 21 Jul 2017

• NCT02369081

  Collaborator, Phase 4, Status unknown, 348 people, 23 Feb 2015

• NCT02237339

  Collaborator, Phase 4, Completed, 72 people, 11 Sept 2014

• NCT02132026

  Collaborator, Phase 2, Completed, 152 people, 6 May 2014

• NCT01997112

  Collaborator, Phase 4, Completed, 100 people, 27 Nov 2013

• NCT01951404

  Collaborator, Phase 4, Completed, 80 people, 26 Sept 2013

• NCT01581476

  Collaborator, Phase 3, Completed, 443 people, 20 Apr 2012

• NCT01457820

  Collaborator, Phase 4, Terminated, 26 people, 24 Oct 2011

• NCT01147705

  Collaborator, Phase 4, Completed, 50 people, 22 Jun 2010

• NCT00994617

  Collaborator, Phase 4, Status unknown, 600 people, 14 Oct 2009

• NCT00731627

  Collaborator, Phase 3, Completed, 803 people, 11 Aug 2008

• NCT00300352

  Collaborator, Phase 2, Status unknown, 60 people, 8 Mar 2006

• NCT00291720

  Collaborator, Phase 2, Completed, 120 people, 14 Feb 2006

• NCT00225355

  Collaborator, Phase 4, Terminated, 80 people, 23 Sept 2005

• NCT00135226

  Collaborator, Phase 4, Active, not recruiting, 15,480 people, 25 Aug 2005

• NCT00125593

  Collaborator, Phase 4, Completed, 9,438 people, 1 Aug 2005

• Pregnancy complications and risk of cardiometabolic-renal conditions in 1.4 million women in England: longitudinal study

  6 Oct 2026

• Patterns and health relevance of neuroticism in Chinese men and women: evidence from the China Kadoorie Biobank

  CH/1996001/9454, 2 Oct 2026

• Retinal vascular trajectories and their associations with systemic health in the Canadian Longitudinal Study on Aging

  RE/24/130017, 2 Oct 2026

• Proteome-wide genetic analyses identify ASGR1 as a potential biomarker linking smoking with ischemic heart disease

  RE/18/3/34214, 22 Sept 2026

• Gene-environment interactions shape cytokine-mediated inflammation and cardiovascular risk

  BBC/F/21/220106, 18 Sept 2026

• Mexico City Prospective Study: cohort profile update

  RE/13/1/30181, 18 Sept 2026

• Incidence patterns and genetic validation of primary glaucoma subtypes among 1 million adults in China and the UK

  CH/1996001/9454, 17 Sept 2026

• A Thematic Narrative Review of Osteoarthritis Risk Factors Across the Female Life Course

  11 Sept 2026

• Prognostic Value of AI-derived Ventricular Imaging Phenotypes from Cardiac CTA for Long-term Risk of Myocardial Infarction ---Analysis of SCOT-HEART Trial

  RE/24/130011, 10 Sept 2026

• Enhanced power and transferability for genetics-driven metabolomic biomarker discovery in admixed American cohorts

  RE/13/1/30181, RG/F/23/110103, CH/12/2/29428, RE/24/130011, SP/09/002, RG/13/13/30194, 7 Sept 2026

• Evaluation of the FI-Lab, a laboratory-based, automated frailty index for acute care: A multicohort study

  Funder of UK Biobank Database, 1 Sept 2026

• Mapping organ fat distribution and body composition: towards precision profiling of cardiometabolic disease risk

  CH/F/21/90009, TG/19/2/34831, RG/F/21/110040, 31 Aug 2026

• Adverse pregnancy outcomes and long-term cardiovascular disease risk

  30 Aug 2026

• Recombinant shingles vaccination and the risk of cardiovascular events

  Oxford BHF Centre of Research Excellence, 26 Aug 2026

• Distinct relationships of compartment-specific fat distribution profiles with cardiovascular ageing and future cardiovascular events

  RE/24/130031, 25 Aug 2026

• Clonal hematopoiesis of indeterminate potential (CHIP), vascular somatic mutation, and cardiovascular disease: A narrative review

  FS/4yPhD/F/23/34194, 24 Aug 2026

• Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study

  RG/F/23/110103, 24 Aug 2026

• Ambient PM2.5 Concentration and the Cardiovascular Response to Exercise Training: A Systematic Review and Meta-Analysis Across Global Pollution Gradients

  RE/24/130031, RG/17/3/32774, 23 Aug 2026

• Adiposity and infection-related mortality: Mendelian randomization study of 126 000 Mexican adults

  RE/13/1/30181, 18 Aug 2026

• Blood Pressure, Kidney Function, and Kidney Mortality Among Mexican Adults

  RE/13/1/30181, 13 Aug 2026

Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov

• Associations of CMR-based pulse wave velocity and aortic distensibility with infrarenal ultrasound-based aortic parameters in the Hamburg City Health Study

  Grants or research support, 21 Sept 2026

• Evaluation of the FI-Lab, a laboratory-based, automated frailty index for acute care: A multicohort study

  Grants or research support, 1 Sept 2026

• Contributions of diet and lifestyle to sex differences in ischaemic heart disease burden in Central Europe: an analysis of the Global Burden of Disease Study 2023

  Grants or research support, 30 Aug 2026

• Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis

  Grants or research support, 18 Aug 2026

• CMR-based aortic stiffness parameters in a symptomatic high risk obstructive sleep apnea cohort: results from the population-based Hamburg City Health Study

  Grants or research support, 13 Aug 2026

• Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF)

  Consulting or advice, Fees or honoraria, 11 Aug 2026

• Prediction of Incident Atrial Fibrillation and Association With Outcomes Using Routine Electronic Health Records in a Western Pacific Population

  Grants or research support, 6 Aug 2026

• Subtyping Alzheimer's disease and Parkinson's disease using longitudinal electronic health records

  Fees or honoraria, Grants or research support, 26 Feb 2026

Sources: pubmed.ncbi.nlm.nih.gov

• Proteomic organ-specific signatures, ageing traits, disease risks and genetic architecture in an East Asian population

  EBioMedicine, 29 Jul 2026

• Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives

  The lancet. Healthy longevity, 21 May 2021